Evozyne

Biotechnology
2 legal entitiesSponsors visas

Facts

as of Nov 17, 2026

ABOUT US Our Mission To design and build engineered protein therapeutics with our AI-native platform, transforming what's possible in immune-mediated disease treatment. Our Vision To establish AI-designed proteins as a foundational therapeutic modality and bring these novel biologics to patients.

Legal name
Evozyne, LLC
Headquarters
Chicago, United States
Founded
2019
Employees
201-500estimated range
Legal entities
2 in 1 countries
Register numbers
NAME evozyne llc
Official records
SEC CIK 1811288
Website
evozyne.com

These are the key facts about Evozyne on Alion as of Nov 17, 2026. Evozyne is headquartered in Chicago, United States. It was founded in 2019. It has raised $144.4M in 3 funding rounds. The latest round is Series B of $81M, announced in 2023.

Sources: company registers, GLEIF, Wikidata, the company's site, Alion job postingsReport a mistake

What the registers and the postings say about this employer.

Legal entity active
Evozyne, LLC
Not checked
Sanctions lists
OFAC SDN, EU consolidated
No match
Phishing reports
OpenPhish, Phishing.Database
None
Layoff notices
US WARN notices on file
None
Full employer checkScam signs in adverts, mail records, visa registers, domain history
Sources: company registers, the Alion truth index, OFAC and EU sanctions lists, US WARN notices

Named in the work visa registers of United States.

0H-1B filings in 12 months
0Open roles in United States

In the register as Evozyne, Inc., Chicago, IL

Other sponsors in the same field
Alert me
US Department of Labor · latest filing Jul 31, 2024

Footprint

Hiring in 1 city in 1 country.

1Cities
1Countries
SiteTypeOpen rolesHires most forEngineering
Chicago United StatesHeadquarters0
Source: office addresses in postings and company registers

Financials

Funding rounds, investors and revenue on record.

$144.4MTotal raised
Series BLatest round
3Rounds and grants
Money by yearUSD, rounds and grants
2023$81M1 record
2021$54.2M1 record
2020$9.2M1 record
Largest rounds and grants
Sources: funding announcements, grant and company registers

Milestones

Each milestone is dated by its source: registers, filings, the press

Newsroom

Jan 302026
News · Nature Index
The Nature Index tracks the affiliations of scientific articles from high-quality publications. The research profile for Evozyne Inc. reflects the research output of authors from…
Jan 4, 20242024
Press release · businesswire.com
Jan 25, 20212021
Press release · PRNewswire
/PRNewswire/ -- Evozyne, LLC, a privately held molecular engineering technology company founded by life science innovator Paragon Biosciences, announced today...
Sources: the outlets named on each headline, each story once